Kasra Maasumi, MD
Interventional Pain Medicine · Rancho Santa Margarita, CANPI 1306161963
Payments from drug & device makers
Across 609 payments — averaging $637.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$181K
- Biohaven Pharmaceuticals, Inc.$115K
- Amgen$34K
- Biohaven Pharmaceutical Holding Company Ltd.$30K
- Lilly USA, LLC$11K
- Teva Pharmaceuticals USA, Inc.$11K
- plus $6K from 16 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 244 | $181,086 |
| Biohaven Pharmaceuticals, Inc. | 161 | $115,212 |
| Amgen | 40 | $33,847 |
| Biohaven Pharmaceutical Holding Company Ltd. | 30 | $29,786 |
| Lilly USA, LLC | 15 | $11,161 |
| Teva Pharmaceuticals USA, Inc. | 34 | $10,520 |
| Medtronic(2 entities) | 32 | $2,671 |
| Spinal Simplicity, LLC | 8 | $2,004 |
| Impel Pharmaceuticals Inc. | 8 | $539 |
| Boston Scientific | 9 | $344 |
| Abbott | 10 | $294 |
| Curonix LLC | 5 | $166 |
| Averitas Pharma Inc. | 1 | $119 |
| Johnson & Johnson | 1 | $74 |
| Stimwave Technologies Incorporated | 2 | $68 |
| Nalu Medical, Inc. | 3 | $50 |
| Pfizer | 1 | $31 |
| Painteq LLC | 1 | $19 |
| Axonics, Inc. | 1 | $16 |
| Relievant Medsystems, Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
How this compares
$388,052 in reported general payments places this provider in the 90th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Rancho Santa Margarita
- Sheldon JordanSanta Monica$3.1M
- Ezekiel FinkBeverly Hills$2.3M
- Matthew DotyOroville$1.3M
- Tim LeierRancho Mirage$749K
- Pragya GuptaEscondido$647K
- Michael Verdolinla Mesa$563K
- Standiford HelmOrange$476K
- Patrick BuchananCamarillo$453K
- Roy BrownlowSan Diego$452K
- Andrew GermanovichRancho Mirage$408K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.